PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18174021-8	2008	These data suggest that the protective effects of galantamine require NF-kappaB activation and iNOS expression, in addition to HO-1.	Galantamine	50-61	nitric oxide synthase 2	Homo sapiens	95-99	
22085833-0	2012	Galantamine elicits neuroprotection by inhibiting iNOS, NADPH oxidase and ROS in hippocampal slices stressed with anoxia/reoxygenation.	Galantamine	0-11	nitric oxide synthase 2	Homo sapiens	50-54	
22085833-7	2012	Furthermore, galantamine reduced iNOS induction and production of NO caused by OGD via Jak2.	Galantamine	13-24	nitric oxide synthase 2	Homo sapiens	33-37	
22085833-9	2012	In conclusion, galantamine afforded neuroprotection under OGD-reoxygenation conditions by activating a signaling pathway that involves nicotinic receptors, Jak2 and the consequent inhibition of NOX and NFkappaB/iNOS.	Galantamine	15-26	nitric oxide synthase 2	Homo sapiens	211-215